Figures & data
Table 1. Characteristics of the study population.
Figure 1. Time course of LEMS: time from first onset of symptoms to first physician visit, time to explicit diagnosis and time between diagnosis and interview. Patients 7, 10, and 12 had a diagnosis of SCLC.
![Figure 1. Time course of LEMS: time from first onset of symptoms to first physician visit, time to explicit diagnosis and time between diagnosis and interview. Patients 7, 10, and 12 had a diagnosis of SCLC.](/cms/asset/02ab6a2e-73b9-4d47-97e2-201603a7b7fd/ijme_a_660897_f0001_b.jpg)
Figure 4. Profile of the EQ-5D scores on the day of interview across domains by patient (1 = no problems, 2 = some problems, 3 = severe problems). Patients 7, 10, and 12 had a diagnosis of SCLC.
![Figure 4. Profile of the EQ-5D scores on the day of interview across domains by patient (1 = no problems, 2 = some problems, 3 = severe problems). Patients 7, 10, and 12 had a diagnosis of SCLC.](/cms/asset/bde431b9-e2c7-45b7-9a32-b398dd29727d/ijme_a_660897_f0004_b.jpg)
Table 2. Utility index and VAS scores on the day of the interview and the 6-day follow-up period. Patients 7, 10, and 12 had a diagnosis of SCLC.
Table 3. Combinations of drug treatment used in current treatment of LEMS.